Valuing the Prevention and Treatment of Liver Disease to Promote Human Wellbeing  

作　　者：Zhi Chen 

机构地区：[1]State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,National Medical Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,Zhejiang,China

出　　处：《Infectious Microbes & Diseases》2022年第2期47-48,共2页感染微生物与疾病（英文）

摘　　要：Over 45 million people suffer from chronic liver disease globally,1,2 and an estimated 2 million deaths are caused by liver diseases globally each year,including 1 million deaths due to cirrhosis and 1 million deaths due to viral hepatitis and hepatocellular carcinoma.3,4 Acute liver failure,chronic viral hepatitis,metabolic dysfunction-associated fatty liver disease(MAFLD),drug-induced liver injury,liver fibrosis,liver cirrhosis,hepatocellular carcinoma.

关 键 词：liver disease PREVENTION TREATMENT 

分 类 号：R575[医药卫生—消化系统]